TY - JOUR
T1 - Antiandrogenic and growth inhibitory effects of ring-substituted analogs of 3,3′-diindolylmethane (Ring-DIMs) in hormone-responsive LNCaP human prostate cancer cells
AU - Abdelbaqi, Khalil
AU - Lack, Nathan
AU - Guns, Emma Tomlinson
AU - Kotha, Leela
AU - Safe, Stephen
AU - Sanderson, J. Thomas
PY - 2011/9/15
Y1 - 2011/9/15
N2 - BACKGROUND Cruciferous vegetables protect against prostate cancer. Indole-3-carbinol (I3C) and its major metabolite 3,3′-diindolylmethane (DIM), exhibit antitumor activities in vitro and in vivo. Several synthetic ring-substituted dihaloDIMs (ring-DIMs) appear to have increased anticancer activity. METHODS Inhibition of LNCaP prostate cancer cell growth was measured by a WST-1 cell viability assay. Cytoplasmic and nuclear proteins were analyzed by immunoblotting and immunofluorescence. Androgen receptor (AR) activation was assessed by measuring prostate-specific antigen (PSA) expression and using LNCaP cells containing human AR and an AR-dependent probasin promoter-green fluorescent protein (GFP) construct. RESULTS Like DIM, several ring-substituted dihaloDIM analogs, namely 4,4′-dibromo-, 4,4′-dichloro-, 7,7′-dibromo-, and 7,7′-dichloroDIM, significantly inhibited DHT-stimulated growth of LNCaP cells at concentrations ≥1 μM. We observed structure-dependent differences for the effects of the ring-DIMs on AR expression, nuclear AR accumulation and PSA levels in LNCaP cells after 24 hr. Both 4,4′- and 7,7′-dibromoDIM decreased AR protein and mRNA levels, whereas 4,4′- and 7,7′-dichloroDIM had minimal effect. All four dihaloDIMs (10 and 30 μM) significantly decreased PSA protein and mRNA levels. Immuofluorescence studies showed that only the dibromoDIMs increased nuclear localization of AR. All ring-DIMs caused a concentration-dependent decrease in fluorescence induced by the synthetic androgen R1881 in LNCaP cells transfected with wild-type human AR and an androgen-responsive probasin promoter-GFP gene construct, with potencies up to 10-fold greater than that of DIM. CONCLUSION The antiandrogenic effects of ring-DIMs suggest they may form the basis for the development of novel agents against hormone-sensitive prostate cancer, alone or in combination with other drugs.
AB - BACKGROUND Cruciferous vegetables protect against prostate cancer. Indole-3-carbinol (I3C) and its major metabolite 3,3′-diindolylmethane (DIM), exhibit antitumor activities in vitro and in vivo. Several synthetic ring-substituted dihaloDIMs (ring-DIMs) appear to have increased anticancer activity. METHODS Inhibition of LNCaP prostate cancer cell growth was measured by a WST-1 cell viability assay. Cytoplasmic and nuclear proteins were analyzed by immunoblotting and immunofluorescence. Androgen receptor (AR) activation was assessed by measuring prostate-specific antigen (PSA) expression and using LNCaP cells containing human AR and an AR-dependent probasin promoter-green fluorescent protein (GFP) construct. RESULTS Like DIM, several ring-substituted dihaloDIM analogs, namely 4,4′-dibromo-, 4,4′-dichloro-, 7,7′-dibromo-, and 7,7′-dichloroDIM, significantly inhibited DHT-stimulated growth of LNCaP cells at concentrations ≥1 μM. We observed structure-dependent differences for the effects of the ring-DIMs on AR expression, nuclear AR accumulation and PSA levels in LNCaP cells after 24 hr. Both 4,4′- and 7,7′-dibromoDIM decreased AR protein and mRNA levels, whereas 4,4′- and 7,7′-dichloroDIM had minimal effect. All four dihaloDIMs (10 and 30 μM) significantly decreased PSA protein and mRNA levels. Immuofluorescence studies showed that only the dibromoDIMs increased nuclear localization of AR. All ring-DIMs caused a concentration-dependent decrease in fluorescence induced by the synthetic androgen R1881 in LNCaP cells transfected with wild-type human AR and an androgen-responsive probasin promoter-GFP gene construct, with potencies up to 10-fold greater than that of DIM. CONCLUSION The antiandrogenic effects of ring-DIMs suggest they may form the basis for the development of novel agents against hormone-sensitive prostate cancer, alone or in combination with other drugs.
KW - LNCaP cells
KW - androgen receptor
KW - dihydrotestosterone
KW - immunofluorescence
KW - prostate specific antigen
KW - ring-DIMs
UR - http://www.scopus.com/inward/record.url?scp=80051663254&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80051663254&partnerID=8YFLogxK
U2 - 10.1002/pros.21356
DO - 10.1002/pros.21356
M3 - Article
C2 - 21321979
AN - SCOPUS:80051663254
VL - 71
SP - 1401
EP - 1412
JO - Prostate
JF - Prostate
SN - 0270-4137
IS - 13
ER -